Executive Details
|
Company Information
|
Amgen Inc. |
| Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science`s promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a broad and deep pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people`s lives. |
| Company Type : PUBLIC |
| Ticker : AMGN |
| Fortune Rank : 171 |
| Primary Industry : Biotechnology |
| Sector : Healthcare |
| |
| Sales : 14268.0 |
| Employees : 20000 |
| Competitors : Abbott Laboratories, AstraZeneca, Aventis, Baxter, Bayer AG, Bristol Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline |
| |
|
Auditor : Ernst & Young LLP |
| Last Update : 2007-07-16 |
|
|
|
SIC Code : 28 |
| |
| |
| |
|